Tag: psychiatry
-
Multi-System Biomarkers for Suicide Risk in MDD: Erythroid, Inflammation, and Metabolism
Introduction: The Need for Multi-System Biomarkers in MDD Major Depressive Disorder (MDD) remains a leading cause of disability worldwide, with suicide risk representing a critical and urgent challenge for clinicians. Traditional risk assessment often relies on clinical history and self-reported symptoms, which can miss biologically meaningful signals. Emerging research points to a multi-system model of…
-
Multi-system Biomarkers for Suicide Risk in Major Depressive Disorder: Erythroid, Inflammatory, and Metabolic Integration
Introduction: The Need for Multi-system Biomarkers in MDD Major Depressive Disorder (MDD) remains a leading cause of disability worldwide, with suicide risk representing a critical and urgent concern. Traditional risk assessment relies heavily on clinical history and self-reported symptoms, which can fail to capture dynamic biological processes that contribute to suicidality. Emerging evidence suggests that…
-
Diagnose Mental Health Problems? Psychiatrist Weighs In
Introduction: The rise of self-diagnosis on social media In the age of instant information, social media has become a go-to source for quick health insights. Posts about anxiety, depression, or bipolar disorder often spark conversations, but they can also lead to self-diagnosis without professional evaluation. In Manila and across the Philippines, mental health conversations online…
-
Diagnosing Mental Health Problems? A Psychiatrist Weighs In
Understanding the Rise of Online Mental Health Diagnoses In an era where information travels at the speed of a click, many people turn to social media for quick answers about mental health. The lines between awareness and self-diagnosis can blur, especially during a global stressor like a pandemic. While social platforms can reduce stigma and…
-
Groundbreaking 4.4 Million Grant Funds First Study of Prefrontal Cortical Stimulation in Severe Bipolar Disorder
Overview of the Breakthrough Funding A University of Minnesota Medical School research team led by Dr. Ziad Nahas has secured a $4.4 million grant to launch the first-in-the-world study assessing prefrontal cortical stimulation as a treatment for severe bipolar disorder. The project, supported by Breakthrough Discoveries, marks a pivotal step in exploring innovative neuromodulation techniques…
-
Breakthrough Grant Advances First Study of Prefrontal Stimulation for Severe Bipolar Disorder
Groundbreaking Investment to Explore Neuromodulation in Bipolar Disorder A University of Minnesota Medical School research team, led by Dr. Ziad Nahas, has secured a $4.4 million grant to pursue a pioneering, first-in-the-world study of prefrontal cortical stimulation as a potential treatment for severe bipolar disorder. The funding comes from Breakthrough Discoveries, signaling strong confidence in…
-
Your DNA and cannabis: genes linked to use and risk
DNA and cannabis: what a new study reveals Researchers have long asked how much our choices around cannabis are shaped by biology versus environment. A landmark study from the University of California, San Diego, in collaboration with DNA testing service 23andMe, provides fresh evidence that genetics play a meaningful role in cannabis use, how often…
-
DNA Clues: How Your Genes May Shape Your Relationship With Cannabis
New genetic links between cannabis use and brain function Researchers are shedding light on why people respond to cannabis in different ways. In one of the largest studies of its kind, scientists from the University of California, San Diego, and the DNA testing service 23andMe analyzed genetic data from more than 130,000 participants who reported…
-
MDMA-Assisted Psychotherapy: Insights from the October 2025 Psychedelics Review on PTSD and Emerging Conditions
Overview: A Historic View of MDMA in Psychotherapy The October 2025 issue of Psychedelics offers a comprehensive review of MDMA-assisted psychotherapy, tracing its journey from early chemical synthesis in 1912 to its current status as a promising tool in modern psychiatry. Led by Dr. Kenji Hashimoto and a multidisciplinary team, the analysis emphasizes how MDMA…
-
MDMA-Assisted Psychotherapy: Insights from the October 2025 Psychedelics Review on PTSD and Emerging Psychiatric Conditions
Overview: A Milestone Review of MDMA-Assisted Psychotherapy The October 2025 issue of Psychedelics presents a comprehensive review of MDMA-assisted psychotherapy, tracing its journey from early synthesis to its current role in modern psychiatric research. Led by Dr. Kenji Hashimoto and a multidisciplinary team, the article synthesizes decades of data to illuminate how MDMA may augment…